Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
Clinical trial NCT02771197 · COMPLETED
Trial details
- NCT number
- NCT02771197
- Sponsor
- Northside Hospital, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-28
- Primary completion
- 2022-08-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.